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Abstract
Introduction:  This  cross-sectional  comparative  study  was  carried  out  at  the  Diabetes  outpatient
clinic of  LAUTECH  Teaching  Hospital  (LTH)  Ogbomoso,  Nigeria.
Objective:  This  study  assessed  patterns  of  otologic  diseases  and  auditory  acuity  among  type  2
diabetics and  determinants  of  these  ﬁndings  among  diabetics.
Methods:  Ninety-seven  consenting  patients  with  clinical  diagnosis  of  diabetes  mellitus  (194
ears) were  matched  for  age  and  sex  with  ninety  non-diabetic  patients  (180  ears).  These  patients
were screened  using  otoscopy  and  pure  tone  audiometry  over  a  6-month  period.
Results: The  study  reported  a  crude  prevalence  rate  of  21.6%  hearing  loss  in  T2DM  patients.  The
most common  type  of  otologic  disease  that  showed  signiﬁcant  association  with  T2DM  patients
was otitis  media  with  effusion  (p  =  0.027).  T2DM  was  signiﬁcantly  associated  with  abnormal
audiometric  ﬁndings  (p  =  0.022),  particularly  sensorineural  hearing  loss  (p  =  0.022),  of  the  mod-
erate grade  (p  =  0.057).  There  were  no  differences  of  the  audilogical  ﬁndings  for  any  particular
ear, and  no  differential  affectation  of  frequency  range  was  observed.  Coexisting  hypertension
and poor  glycaemic  control  were  signiﬁcantly  associated  with  aggravation  of  the  hearing  of  the
T2DM patients  (p  <  0.001,  and  p  =  0.009  respectively). Please cite this article as: Adebola SO, Olamoyegun MA, Sogebi OA, Iwuala SO, Babarinde JA, Oyelakin AO. Otologic and audiologic
characteristics of type 2 diabetics in a tertiary health institution in Nigeria. Braz J Otorhinolaryngol. 2016;82:567--73.
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Conclusion:  T2DM  had  appreciable  effects  on  hearing  acuity.  T2DM  was  signiﬁcantly  associated
with the  type  and  the  degree  of  the  hearing  loss.  The  need  for  screening  of  hearing  acuity  of
T2DM patients,  in  order  to  detect  early  changes,  and  promptly  offer  an  adequate  management
and remedial  measures  was  emphasized  in  this  study.
© 2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published
by Elsevier  Editora  Ltda.  This  is  an  open  access  article  under  the  CC  BY  license  (http://
creativecommons.org/licenses/by/4.0/).
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Características  audiológicas  e  otológicas  de  diabéticos  tipo  2  em  uma  instituic¸ão
de  saúde  terciária  na  Nigéria
Resumo
Introduc¸ão:  Este  estudo  de  caso-controle  foi  realizado  no  Ambulatório  de  Diabetes  do  LAUTECH
Teaching  Hospital  (LTH),  em  Ogbomoso,  Nigéria.
Objetivo:  Este  estudo  avaliou  os  padrões  de  doenc¸as  otológicas  e  acuidade  auditiva  entre  os
diabéticos tipo  2  e  os  fatores  determinantes  desses  achados  entre  os  diabéticos.
Método: Ao  todo,  97  pacientes  com  diagnóstico  clínico  de  diabetes  melito  (194  orelhas)  deram
seu consentimento  e  foram  pareados  por  idade  e  sexo,  com  90  pacientes  não  diabéticos
(180 orelhas).  Eles  foram  avaliados  por  otoscopia  e  audiometria  tonal  liminar  por  um  período
de seis  meses.
Resultados:  O  estudo  relatou  uma  taxa  de  prevalência  bruta  de  21,6%  de  perda  auditiva  em
pacientes  com  DM2.  O  tipo  mais  comum  de  doenc¸a  otológica,  afetando  signiﬁcativamente
pacientes  com  DM2,  foi  otite  média  com  efusão  (p  =  0,027).  A  DM2  foi  associada  com  achados
audiométricos  alterados  (p  =  0,022),  principalmente  perda  auditiva  neurossensorial  (p  =  0,012),
de grau  moderado  (p  =  0,057).  Não  houve  predilec¸ão  dos  efeitos  da  DM2  para  uma  das  orelhas
em particular,  e  também  não  houve  efeito  diferencial  da  faixa  de  frequência.  A  coexistência  de
hipertensão  e  controle  glicêmico  inadequado  associou-se  signiﬁcativamente  à  piora  da  audic¸ão
dos pacientes  com  DM2  (p  <  0,001  e  p  =  0,009,  respectivamente).
Conclusão:  A  DM2  mostrou  apresentar  efeitos  signiﬁcantes  na  acuidade  auditiva  afetando  sig-
niﬁcativamente  o  tipo  e  o  grau  da  disacusia.  Este  estudo  mostrou  a  necessidade  de  avaliac¸ão
da acuidade  auditiva  de  pacientes  com  DM2,  a  ﬁm  de  detectar  as  alterac¸ões  iniciais,  e  poder
rapidamente  oferecer  medidas  corretivas  adequadas.
© 2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
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introduction
iabetes  mellitus  is  a  chronic  metabolic  disorder  character-
zed  by  hyperglycemia  due  to  inadequate  insulin  secretion,
neffective  action  or  a  combination  of  these.  Worldwide,
he  prevalence  of  diabetes  is  increasing  although  the  rate
aries  from  countries,  races  and  religion.  It  has  been  esti-
ated  that  the  prevalence  of  diabetes  will  increase  from
resent  382  million  to  592  million  by  2035.1 The  vast  major-
ty  of  diabetes  cases  fall  into  2  major  etiopathogenetic
ategories,  Type  1  diabetes  which  occurs  as  a  result  of
bsolute  deﬁciency  of  insulin  secretion  and  Type  2  dia-
etes  which  is  caused  by  a  combination  of  insulin  resistance
nd  a  faulty  compensatory  insulin  secretory  response.2
ther  categories  include;  Other  speciﬁc  types  (caused  by
peciﬁc  genetic  defects,  surgery,  drugs);  Gestational  Dia-
etes  Mellitus  (GDM);  Impaired  Glucose  Tolerance  (IGT)  and
mpaired  Fasting  Glucose  (IFG).2 Type  2  diabetes  mellitus
T2DM)  accounts  for  80%--90%  of  all  cases  of  diabetes  and  is
losely  related  to  obesity  among  other  risk  factors.  It  is  a
e
p
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aultisystem  disorder  with  a  propensity  to  affect  the
ardiovascular  system,  and  produces  varying  chronic
icrovascular  and  macrovascular  complications.  Amongst
he  complications,  hearing  loss  remains  one  of  its
ost-distressing  and  least  understood  phenomenon.  Thus
esearchers  have  proposed  various  hypotheses  includ-
ng  micro-angiopathy  and  neuropathy  to  explain  the
omplication.3--5 Infact,  studies  have  demonstrated  that
he  micro-angiopathy  in  Type  2 Diabetes  Mellitus  (T2DM)
nvolves  mostly  the  cochlear  with  associated  degeneration
f  the  stria  vascularis  and  cochlear  outer  hair  cells.6,7
The  pattern  of  hearing  loss  in  diabetes  has  been  shown
n  many  studies8--14 to  be  moderately  severe  in  magni-
ude,  progressive  in  nature,  and  bilateral  in  occurrence
nd  may  be  irreversible.  The  prevalence  of  hearing  loss
n  diabetics  in  Nigerian  population  has  not  been  studied
9,15xtensively. This  study  was  undertaken  to  describe  the
attern  of  otologic  diseases  and  auditory  acuities  in  T2DM
atients  comparing  this  with  those  of  non-diabetics  and  to
lso  explore  the  determinants  of  these  patterns.  This  is
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bOtologic  and  audiologic  characteristics  of  type  2  diabetics  in
important  because  type  2  diabetes  mellitus  is  a  public  health
problem,  which  signiﬁcantly  and  negatively  affect  the  qual-
ity  of  life  when  complicated  with  hearing  loss.15
Methods
Study  design
This  cross-sectional  and  comparative  study  was  carried  out
on  patients  attending  the  Endocrinology  and  General  out-
patient  clinics  in  Ladoke  Akintola  University  of  Technology
Teaching  Hospital  (LTH)  Ogbomoso,  Nigeria.  One  hundred
and  87  patients  were  divided  into  two  groups  based  on  their
diabetes  status;  Group  I  consisted  of  97  patients  diagnosed
with  type  2  diabetes  (T2DM),  attending  the  endocrinol-
ogy  clinic  and  the  group  two  consisted  of  90  non-diabetic
patients  attending  the  general  outpatient  clinic,  which  were
matched  for  age  and  sex  with  the  study  group.  The  study  was
carried  out  over  a  6  month  period  from  December  2013  to
May  2014.
The  study  was  approved  by  the  institutional  Ethics  com-
mittee  of  the  Ladoke  Akintola  University  of  Technology
Teaching  Hospital  (LTH)  Ogbomoso,  Nigeria.  Appropriate
sample  size  was  determined  according  to  the  methodology
of  other  published  and  relevant  studies.14
Sampling  technique:  Consecutive  adult  patients  attend-
ing  each  of  these  clinics  were  approached  as  potential
subjects.  The  purpose,  nature,  signiﬁcance  of  the  study  was
explained  to  each  of  the  subjects;  those  that  consented
were  recruited  as  subjects.  The  main  inclusion  criteria  for
group  one  were:  known  diabetic  patients  who  had  attended
at  least  2  visits  at  outpatient  diabetic  clinics,  aged  ≥  30
years  with  a  conﬁrmed  diagnosis  of  T2DM  based  on  WHO
criteria  of  Fasting  Plasma  Glucose  (FPG)  of  ≥  126  mg/dL
(7  mmoL/L),  regarded  as  the  test  subjects.  For  the  patients
of  the  group  two,  normal  blood  glucose  level  (taken  as  FPG
<  110  mg/dL  (6.1  mmoL/L)  served  as  controls.  A  diagnosis  of
hypertension  was  made  in  patients  with  systolic  blood  pres-
sure  >  140  mmHg  and  diastolic  blood  pressure  >  90  mmHg.
Patients  with  history  of  consumption  of  ototoxic  drugs
within  three  months,  previous  history  of  ear  surgeries,
recent  infections  in  the  ear,  nose  and  throat,  history  sug-
gestive  of  exposure  to  noise  induced  hearing  loss  were
excluded.  Data  were  generated  from  the  information
extracted  from  the  participant  by  the  researchers  using
an  interviewer-administered  questionnaire.  The  information
obtained  included  socio-demographic  parameters  like  the
age  last  birthday,  sex,  social  classes16 and  occupation  of  each
participant.
The  weight  measured  in  kilograms  (kg)  of  the  subjects
were  taken  by  using  Omron  HN-283  digital  body  weight  scale,
and  the  height  measurements  in  metres  (m)  were  taken
by  Seca  Leicester  standiometer.  The  Body  Mass  Index  (BMI)
was  calculated  as  weight  in  kg/(height  in  metres)2.  The
ranges  of  the  BMI  were;  underweight  (<  18.0),  normal  weight
(18.1--24.9),  overweight  (25.0--29.9),  Obese  (>  30.0),  Types
1  to  3  (30.0--34.5,  35.0--39.9  and  >  40  respectively).Plasma  glucose  levels  were  measured  for  each  partici-
pant,  after  withdrawing  2  mls  of  venous  blood  from  each
individual  after  an  overnight  fast  of  at  least  eight  hours.
The  values  obtained  was  using  in  classifying  the  patients  into
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ither  of  the  groups.  The  other  laboratory  data  determined
n  diabetic  patients  was  glycated  haemoglobin  (HbA1c)  using
oint  of  Care  machine  (In  2  ItR).  HbA1c  < 7%  was  consid-
red  as  good  glycaemic  control  and  >  7%  as  poor  glycaemic
ontrol.
toscopic  and  audiologic  screening
toscopic  examination  was  performed  on  both  ears  by  a
onsultant  Otolaryngologist  using  a  pneumatic  otoscope.
he  ﬁndings  of  the  outer  ear,  external  auditory  canal  and
he  status  of  the  tympanic  membrane  were  recorded.  Only
ne  major  diagnosis  made  from  each  ear  was  recorded.
neumatic  otoscopy  was  carried  out  to  test  mobility  of  the
ympanic  membrane  using  the  Welch  Allyn  3.5  v  pneumatic
toscope  (Model  20200).
Diagnostic  pure  tone  audiometry  was  performed  in  a
ound-proof  booth  with  ambient  noise  of  <  45  dB  using  a  cali-
rated  2  channel  audiometer  (MA  53,  Maico  Inc.)  by  the  same
udiologist  on  all  the  subjects.  Air  conduction  thresholds
easured  at  frequencies  250,  500,  1000,  2000,  4000,  6000,
000  Hertz,  while  the  bone  conduction  thresholds  were  mea-
ured  at  the  frequencies  250,  500,  1000,  2000,  4000  Hz  for
ach  ear  separately.  The  method  used  was  based  on  the
merican  Speech  Hearing  Association  (ASHA)  guidelines  for
anual  pure  tone  audiometry.15
tatistical  analysis
ll  statistical  analysis  were  done  using  SPSS  statistical
ackage  for  Windows,  version  18  (SPSS  Inc.,  Chicago,  IL).
he  results  were  presented  in  simple  charts  and  tables
s  appropriate  descriptive  analyses.  Comparative  analyses
f  the  different  variables  were  performed  between  the
2DM  patients  and  controls.  Differences  between  categori-
al  variables  were  explored  using  the  Chi-  square  test,  while
hose  between  continuous  variables  were  explored  using  stu-
ent  t-test.  Factors  associated  with  hearing  impairment  in
he  diabetics  were  also  explored.  All  analyses  were  done
ith  statistical  signiﬁcant  level  set  at  p  <  0.05.
esults
here  were  one  hundred  and  eighty  seven  patients  compris-
ng  of  97  test-subjects  with  type  2  diabetes  (T2DM)  and  90
ontrol  subjects  without  diabetes  who  participated  in  this
tudy.  The  gender  distribution  among  T2DM  (44  males  and  53
emales)  and  the  controls  (40  males  and  50  females)  were
imilar  (p  =  0.899).  The  low  socio  economic  class  (groups  IV
nd  V)  constituted  62.9%  and  52.1%  for  the  test  subjects
nd  controls  respectively,  with  no  statistically  signiﬁcant
ifference  (p  =  0.693).  The  body-mass  index  (BMI)  of  the
articipants  showed  that  80.4%  of  diabetics  had  BMI  ≥
0.0  compared  to  56.7%  of  controls  (p  <  0.001).  There  were
o  signiﬁcant  differences  in  the  otoscopic  ﬁndings  such  as
erumen  impaction  and  tympanic  membrane  perforations
etween  the  two  groups  of  patients  (p  =  0.781  and  0.083
espectively).  However,  a  signiﬁcant  higher  number  of  T2DM
atients  had  OME  (p  =  0.027).  Other  socio-demographic  and
linical  characteristics  of  participants  are  as  seen  in  Table  1.
he  mean  duration  of  diabetes  was  7.6  years  (S.D  =  6.4),
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Table  1  Socio-demographic  and  clinical  characteristics  of  the  participants.
Diabetics  Controls
Parameter  n  =  97  (%)  n  =  90  (%)  2 p-value
Gender  of  participants
Male  44  (45.4)  40  (44.4)
Female  53  (54.6)  50  (55.9)  0.016  0.889
Age range  (years)
30--39  10  (10.3)  10  (11.1)
40--49 18  (18.6)  16  (17.8)
50--59 11  (11.3)  12  (13.3)
60--69 35  (36.1)  30  (33.3)
70--79 12  (12.1) 12  (13.3)
≥ 80 11  (11.3) 10  (11.1)
Mean ±  SD  58.9  ±  14.95  58.8  ±  14.71  0.997
Socio-economic  class
I 8  (8.2)  9  (10.0)
II 11  (11.3)  14  (15.6)
III 17  (17.6)  20  (22.2)
IV 28  (28.9)  21  (23.3)
V 33  (34.0)  26  (28.9)  2.234  0.693
Body Mass  Index  (BMI)
Healthy  weight  19  (19.6)  39  (43.3)
Overweight  27  (27.8)  31  (34.4)
Obesity  type  1  15  (15.5)  11  (12.3)
Obesity  type  2  36  (37.1)  9  (10.0)  23.759  <0.001a
Otoscopic  ﬁndings  n  =  194  (%)  n  =  180  (%)
Normal  99  (51.0)  116  (64.4)  1.344  0.246
Impacted Cerumen  auris  27  (13.9)  25  (13.9)  0.077  0.781
Otitis Media  with  Effusion 38  (19.6)  21  (11.7)  4.898  0.027a
Perforated  Tympanic  membrane  30  (15.5)  18  (10.0)  3.000  0.083
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hile  diagnosis  <  1  year  period  was  the  most  prevalent,
7.8%,  the  details  of  the  distribution  is  in  Fig.  1.
Abnormal  pure  tone  audiometry  (PTA)  ﬁndings  were
resent  in  21.5%  (21)  and  8.9%  (8)  of  the  T2DM  and  controls
espectively,  which  was  statistically  signiﬁcant  (p  =  0.016).
he  affectation  of  the  ears  of  participants  with  abnor-
al  PTA  ﬁndings  was  unilateral  in  ﬁve  of  the  twenty-one
2DM  patients  (5/21,  23.8%)  and  six  of  the  ten  controls
6/10,  75.0%).  The  number  of  participants  with  abnormal
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7TA,  with  bilateral  ear  involvement  found  in  T2DM  patients
as  signiﬁcantly  higher  than  in  controls  (p  =  <  0.001).  The
ost  prevalent  type  of  hearing  loss  recorded  among  T2DM
atients  (in  61.9%)  was  sensorineural  hearing  loss  which  was
igniﬁcantly  different  (p  = 0.012)  from  the  37.5%  recorded
mong  the  controls.  The  degree  of  hearing  loss  most  com-
on  amongst  T2DM  patients  and  controls  in  the  study  was
oderate  hearing  loss,  38.0%  (8/21)  and  mild  hearing  loss,
7.5%  (3/8)  respectively,  which  were  not  statistically  signif-
cant  (Table  2).
There  were  some  differences  noted  between  the  T2DM
roup  and  the  control  group  in  the  two  pure  tone  average
PTAv)  groups  computed:  PTAv-1  (0.5,  1,  2  kHz)  and  PTAv-2
4,  6,  8  kHz).  Diabetics  needed  more  sound  intensity  for
he  detection  of  PTA  threshold  as  compared  with  controls
Fig.  2).  The  average  threshold  differences  ranged  from  8.5
o  12.2  decibels  (dB)  in  the  right  ear,  and  from  6.4  to  9.4  dB
n  the  left  ear.  These  differences  were  not  statistically  sig-
iﬁcant.
A total  of  21  participants  with  T2DM  had  hearing  impair-
ent  (bilateral  in  16  and  unilateral  in  5)  out  of  a  total  of  97
2DM  patients  screened.  This  gave  a  crude  prevalence  rate
f  21.6%.  Among  the  subjects  with  T2DM  alone  abnormal
TA  results  were  found  in  28.6%  while  it  was  found  among
1.4%  of  patients  with  T2DM  co-existing  with  hypertension
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Table  2  Audiologic  characteristics  of  the  participants.
Diabetic  patients  Controls
Parameter  n  =  97  (%)  n  =  90  (%)  2 p-value
Abnormal  PTA  ﬁndings
No  76  (78.4)  82  (91.1)
Yes 21  (21.5)  8  (8.9)  5.828  0.016*
Level of  involvement
Unilateral  5  (23.8)  6  (75.0)  0.091  0.763
Bilateral 16  (76.2)  2  (25.0)  10.889  <  0.001*
Type of  hearing  loss
Conductive  HL 3  (14.2) 2  (25.0) 0.250 0.650
Sensori-neural  HL 13  (61.9) 3  (37.5) 6.250 0.012a
Mixed  HL  5  (23.9)  3  (37.5)  0.500  0.480
Degree of  the  hearing  loss
Mild  (26--40  db)  4  (19.0)  3  (37.5)  0.143  0.705
Moderate (41--60  db)  8  (38.0)  2  (25.0)  3.600  0.057
Severe (61--80db) 5  (24.0)  2  (25.0)  1.286  0.257
Profound (>  80  db) 4  (19.0) 1  (12.5)  1.800  0.180
PTA, Pure Tone Audiometry; HL, Hearing Loss.
a Statistically signiﬁcant.
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rentFigure  2  Pure  tone  audiometric  averages  at  dife(p  <  0.001).  Comparing  the  audiograms  between  patients
with  good  and  poor  glycaemic  control,  revealed  signiﬁcant
differences  in  between  the  two  groups  of  patients  (p  =  0.009)
in  Table  3.
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Table  3  Showing  the  relationship  between  diabetic  parameters  a
Diabetes  mellitus  parameters Audiolo
Normal  PTA  n  =  76  (%)
Co-Morbidities
Diabetes  mellitus  alone  33  (43.4)  
Diabetes  mellitus  with  hypertension  43  (56.6)  
Glycemic  Control
Good  control  (HbA1c  <  7%)  52  (68.4)  
Poor control  (HbA1c  <  7%)  24  (31.6)  
a Statistically signiﬁcant.e  frequency  ranges  according  to  subject  category.iscussion
he  study  found  that  the  main  otological  disease  associated
ith  T2DM  patients  in  our  environment  was  otitis  media  with
nd  hearing  impairment  of  participants.
gic  parameters 2 p-value
 Abnormal  PTA  n  =  21  (%)
6  (28.6)
15  (71.4)  13.517  <  0.001a
12  (57.2)
9  (42.8)  6.818  0.009a
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ffusion.  There  were  signiﬁcant  impacts  of  T2DM  on  the
udiological  characteristics  namely  abnormal  audiometric
hapes,  sensorineural  type  of  hearing  loss,  involving  the  two
ars.  T2DM  did  not  differentially  affect  any  frequency  range
nd  had  no  effect  on  the  degree  of  hearing  loss.  Hearing
mpairment  in  T2DM  patients  were  aggravated  by  co-existing
ypertension  and  poor  glycaemic  control.
While  the  socio-demographic  characteristics  of  the  two
ategories  of  patients  were  generally  similar,  signiﬁcantly
ore  of  the  diabetic  patients  were  obese  or  at  least  had
nhealthy  weights  similar  to  previous  studies.4,17 The  pre-
onderance  of  the  low  socio-economic  class,  62.9%  and
2.1%  in  both  T2DM  patients  and  controls  in  the  study  sug-
est  the  peculiarities  of  this  class  of  individuals.  The  level
f  education  in  this  class  tend  to  be  low  as  compared  with
he  higher  classes  and  added  to  this  fact  is  the  tendency
o  take  diets  that  may  not  be  balanced  nutritionally,  pre-
isposing  to  obesity.  Obesity  had  been  established  as  one
f  the  risk  factors  for  T2DM,18 and  maintenance  of  healthy
eight  has  been  mentioned  among  the  ways  for  preventing
evelopment  of  T2DM.17,19 Furthermore,  weight  reduction
emains  one  of  the  key  lifestyle  modiﬁcation  strategies  that
as  been  deployed  in  the  management  of  T2DM.20,21
While  the  spectrum  of  otologic  diseases  found  in  this
tudy  was  varied,  it  was  only  otitis  media  with  effusion  (OME)
hat  was  found  to  be  signiﬁcantly  associated  with  T2DM.
his  ﬁnding  is  corroborated  by  previous  studies  in  develop-
ng  countries,22 where  immune-compromised  state  has  been
mplicated  as  a  predisposing  factor  to  developing  chronic  ear
isease  especially  with  anaerobic  bacteriology  in  middle  ear
solates.  Nasal  mucociliary  action  tends  to  be  decreased  in
iabetics,  which  might  predispose  to  OME.23 The  study  of
ee,  Sun  Kyu24 which  examined  the  relationship  between
aediatric  obesity  and  OME,  noted  that  obesity  results  in
ltered  cytokine  expression,  gastroesophageal  reﬂux  dis-
ase  and  fat  accumulation,  which  may  eventually  result  in
ME.  There  may  be  need  for  further  research  on  the  rela-
ionship  between  T2DM  and  OME,  to  explore  and  ﬁll  the
bvious  gap  in  knowledge  concerning  these  phenomena.
Two  otological  diseases,  namely  otomycosis  and  necrotiz-
ng  (malignant)  otitis  externa  (NOE)  have  been  reportedly
ssociated  with  diabetes  were  not  found  in  this  study.
tomycosis  is  a  fungal  infection  which  thrives  in  the  ear
hen  the  systemic  immunity  is  generally  compromised  espe-
ially  in  poor  glycaemic  control.  The  common  practice  of
any  of  our  patients  instilling  off-the-shelf  anti-microbial
nd  antifungal  ear  drops  into  the  ear  canals  which  might
nadvertedly  treat  otomycosis,  and  may  be  responsible  for
ts  absence  in  this  population.  It  is  also  possible  that  our
atients’  diabetic  control  was  not  bad,  especially  when  the
imple  majority  (27.8%)  among  them  were  diagnosed  within
ne  year  of  noticing  the  symptoms.  This  may  also  be  respon-
ible  for  the  absence  of  NOE  in  this  study.  However,  it  is
ossible  that  some  of  these  pathologies  were  missed  or  mis-
iagnosed  as  the  special  tests  required  for  their  diagnoses
ike  newer  molecular  detection  methods  available  as  pre-
ackaged  kits  (yeast  star,  auxocoloretic),25 immunoassay
ith  monoclonal  antibodies,  and  polymerase  chain  reaction
PCR)  were  not  carried  out  in  the  study.
Signiﬁcantly  more  of  the  T2DM  patients  in  this  study
ere  found  to  have  abnormal  audiologic  characteristics,
articularly  of  the  sensorineural  type  that  affected  the  two
a
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ars.  The  systemic  nature  of  the  disease  will  tend  to  affect
he  two  ears,  and  there  might  not  be  a  lateralization  to
 particular  ear.  This  is  in  tandem  with  ﬁndings  from  other
esearchers.26 In  patients  with  diabetes,  two  possible  mech-
nisms  had  been  muted  which  includes  microangiopathic
hanges  involving  all  the  major  blood  vessels  including  that
f  the  inner  ear  in  T2DM  patients7,11 Secondly  there  could
e  primary  neuropathy  of  the  cochlear  nerve  leading  to
etro-cochlear  hearing  loss.12 The  hearing  impairment  in  this
tudy  signiﬁcantly  affected  both  ears.  Ciorba  et  al.8 in  a
arge  cohort  study  that  evaluated  inner  ear  changes  result-
ng  from  micro-vascular  disease  in  T2DM  patients,  however
eported  that  the  association  of  SNHL  with  T2DM  was  not
onclusive.
Some  previous  studies  have  not  identiﬁed  any  relation-
hip  between  duration  of  diabetes,  presence  and  degree
f  hearing  loss.12--14 Similarly  in  this  study,  we  found  that
2DM  did  not  differentially  affect  any  frequency  range  and
ad  no  effect  on  the  degree  of  hearing  loss.  Systemic  dis-
ases  like  presbycusis,  and  noise  induced  hearing  loss  have
een  reported  to  differentially  affect  the  high  frequency
ones,27 while  Frisina  et  al.,  in  a  study  in  USA,  found  the
reatest  hearing  deﬁcits  at  the  lower  frequencies  among
atients  with  T2DM.28 Mozaffari  et  al.29 in  the  study  car-
ied  out  in  Iran  amongst  the  non-elderly  population  (<  60
ears  old),  however  noted  that  age  at  onset  and  duration
f  diabetes  mellitus  were  predisposing  factors  to  acquiring
earing  loss  in  diabetics.  It  is  obvious  in  this  study  that  T2DM
igniﬁcantly  affected  hearing  of  the  subjects.  Thus  certain
ctions  may  be  necessary  especially  as  hearing  impairment
tself  can  constitute  a  major  morbidity.  The  management
f  T2DM  will  require  a  multidisciplinary  approach  involving
he  diabetologist,  the  dietitian,  the  otologist,  audiologist
nd  possibly  the  neurologist.  We  propose  that  screening  of
earing  acuities  with  diagnostic  pure  tone  audiometry  be
erformed  at  diagnosis  of  T2DM,  and  at  least  six-monthly
ntervals  on  the  initial  results  of  the  tests.  This  will  allow
arly  detection  of  auditory  anomalies,  permit  prompt  and
dequate  management  to  be  offered  and  remedial  measures
nstituted  as  appropriate.
Hearing  impairment  in  T2DM  patients  are  aggravated  by
o-existing  hypertension  and  poor  glycaemic  control.  This
s  in  keeping  with  ﬁndings  of  Duck  et  al.,30 whose  study
upported  the  hypothesis  that  the  presence  of  end-organ
amage  in  diabetics,  tends  to  be  exacerbated  in  the  co-
xisting  hypertension.  However  the  impact  of  hypertension
n  T2DM  patients  in  this  study  must  be  made  cautiously,
s  other  known  and  reported  confounders  like  hypercho-
esterolemia,  heavy  smoking,  and  genetic  predisposition18
ere  not  controlled  for.  Furthermore,  as  reported  in  some
ther  studies9,12,31 we  found  that  hearing  impairment  in
2DM  patients  were  also  aggravated  by  poor  glycaemic  con-
rol.  Prolonged  accumulation  of  products  of  glycation  in
he  inner  ear,  especially  the  outer  hair  cell  function  has
een  attributed  to  be  responsible  for  the  hearing  impair-
ent  associated  with  poor  glycaemic  control  among  T2DM
atients.  However,  this  explanation  is  not  deﬁnitive,  espe-
ially  as  some  other  studies  had  not  found  a  signiﬁcant
ssociation  between  these  two  phenomena,32 The  exact
echanisms  of  glycosylation  on  the  hair  cell  functions  is  the
ubject  of  some  on-going  experimental  research  studies  with
nimal  models.
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3Otologic  and  audiologic  characteristics  of  type  2  diabetics  in
The  study  was  limited  by  its  hospital-based  nature,  and
the  fact  that  other  confounders  and  co-morbidities  were  not
subjected  to  control.  A  larger  population-based  epidemio-
logical  study  might  be  necessary  for  better  elucidation  of
this  important  subject.
Conclusion
In  conclusion,  this  study  found  that  T2DM  had  appreciable
effects  on  hearing  acuity,  showing  a  signiﬁcant  association
between  the  disease  and  the  type  and  the  degree  of  the
hearing  loss.  There  is  a  need  for  screening  of  hearing  acuity
of  T2DM  patients,  in  order  to  detect  the  changes  early,  offer-
ing  a  prompt  adequate  management  and  remedial  measures
as  appropriate.
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